(Q43867300)

27 November 2017

Prolonged effect of an anesthetic dose of ketamine on behavioral despair (English)

1 reference

27 November 2017

Yilmaz A

1

1 reference

27 November 2017

Schulz D

series ordinal

2

1 reference

27 November 2017

Aksoy A

series ordinal

3

1 reference

27 November 2017

Canbeyli R

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Pharmacology, Biochemistry and Behavior

27 November 2017

1 reference

27 November 2017

71

1 reference

27 November 2017

1-2

1 reference

27 November 2017

341-344

1 reference

NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure--implications for anxiety associated with posttraumatic stress disorder.

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Effects of the NMDA receptor antagonist ketamine on flavor memory: conditioned aversion, latent inhibition, and habituation of neophobia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Forced swim test-induced neurochemical endocrine, and immune changes in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Altered metabolic activity in the cerebral cortex of rats exposed to ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Previous stress increases in vivo biogenic amine response to swim stress

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Effects of minaprine and sulpiride injected into the amygdaloid nucleus on the duration of immobility in rats forced to swim

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

1 reference

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Ketamine blocks a conditioned taste aversion (CTA) in neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

A single pretreatment with MK-801 or cocaine enhances their locomotor stimulant effects in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Intracortical glutamate injection produces helpless-like behavior in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Depression: a new animal model sensitive to antidepressant treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Behavioural despair in rats: A new model sensitive to antidepressant treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Ketamine: an update on the first twenty-five years of clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Ketamine--its pharmacology and therapeutic uses.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Animal models of depression: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

Effects of dopamine antagonists on changes in spontaneous EEG and locomotor activity in ketamine-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900693-1

7 January 2021

10.1016/S0091-3057(01)00693-1

Identifiers

DOI

1 reference

27 November 2017

1 reference